Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001193125-26-131745

Director bought 5,000 shares at $8.79 ($43,950)

From the SEC's structured data for this filing

Trades in this filing

Shannon James Samuel · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-26 Purchase : show line 1 in the form +5,000 $8.79 $43,950 10,000 D
Open-market purchases · 5,000 sh · avg $8.79 · $43,950
Loading xslF345X06/ownership.xml…